Despite biological plausibility [1] and considerable epidemiological evidence [6,21–23] suggesting that vitamin E plays a protective role in CRC development [8], human trials have not supported the anticarcinogenic effect of supplemental vitamin E. A possible explanation for this inconsistency is the interactive effect of COMT and supplemental vitamin E on cancer [9]. Here, COMT is linked to colorectal carcinoma.